KURA

KURA R&D Expense Growth

47.72%Fiscal year

Period ending:

KURA FY R&D Growth (YoY)%
KURA FY R&D Growth (YoY)135.46%-14.51%
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

KURA r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Kura Oncology Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
47.7193%
47.496%
24.1596%
9.5502%
40.2735%
26.2849%
2.2207%
77.0491%
29.5138%
14.7775%
120.9421%
0%
0%
0%
0%
0%
0%
0%

Compare r&d expense growth

All KURA financial metrics · KURA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.